Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)

BRIDGEWATER, N.J., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis Laboratories FL, Inc.... Biopharmaceuticals, Generics, Litigation Amneal Pharmaceuticals, Actavis Laboratories FL, Actavis Pharma, Rytary
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news